Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients

Abstract Background Infection with SARS‐CoV‐2 leads to COVID‐19, the course of which is highly variable and depends on numerous patient‐specific risk factors. Patients with tumor diseases are considered to be more susceptible to severe COVID‐19; however, they also represent a heterogeneous group of...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Alexander Kiani, Romina Roesch, Clemens M. Wendtner, Frank Kullmann, Thomas Kubin, Thomas Südhoff, Marinela Augustin, Markus Schaich, Clemens Müller‐Naendrup, Gerald Illerhaus, Frank Hartmann, Holger Hebart, Ruth Seggewiss‐Bernhardt, Martin Bentz, Ernst Späth‐Schwalbe, Peter Reimer, Ulrich Kaiser, Markus Kapp, Ullrich Graeven, Jens‐Marcus Chemnitz, Jörg Baesecke, Helmut Lambertz, Ralph Naumann
Format:	Article
Language:	English
Published:	Wiley 2021-07-01
Subjects:	biomarkers cancer COVID‐19 neutrophils SARS‐CoV‐2 tumor
Online Access:	https://doi.org/10.1002/cam4.4023